The potential of microRNAs as non-invasive prostate cancer biomarkers: A systematic literature review based on a machine learning approach

E Bevacqua, S Ammirato, E Cione, R Curcio, V Dolce… - Cancers, 2022 - mdpi.com
Prostate cancer can be clinically insignificant (low-risk and localized to the prostate) or …
embedded tissue (FFPE) due to the stable nature of miRs, by using microarrays, next generation …

Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial

R Phillips, WY Shi, M Deek, N Radwan, SJ Lim… - JAMA …, 2020 - jamanetwork.com
local progression, any evidence of progression by size was … is whether we can alter the
natural history of OMPC with MDT. … However, our analysis was limited by the small fraction of …

Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men

N Swami, YA Baez, I Franco, T Nguyen… - … cancer and prostatic …, 2023 - nature.com
… Despite great heterogeneity amongst Hispanic groups, prostate cancer studies often report
Hispanic patients in aggregate. We sought to identify differences in prostate cancer risk …

Artificial intelligence applications in prostate cancer

A Baydoun, AY Jia, NG Zaorsky, R Kashani… - … cancer and prostatic …, 2024 - nature.com
… PCa also exhibits a remarkably heterogeneous natural history [9] … predictive biomarkers in
localized prostate cancer. Hence, … A systematic review of the AI application for prostate cancer

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective …

MS Hofman, N Lawrentschuk, RJ Francis, C Tang… - The Lancet, 2020 - thelancet.com
… patients with high-risk localised prostate cancer. Despite careful … The natural history and
predictors of outcome following … -line imaging analysis include the fact that the analysis was of a …

Prostate cancer dormancy and recurrence

FC Cackowski, EI Heath - Cancer letters, 2022 - Elsevier
… In a meta-analysis of nearly 63,000 patients with localized … After excluding cells thought to
be contaminating normal marrow … In the current review, we concentrate on recent advances. …

Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review

K Patell, M Kurian, JA Garcia, P Mendiratta… - Expert Review of …, 2023 - Taylor & Francis
… A limitation to this review is its retrospective nature, which makes it difficult to compare
patient … In addition, future studies will look into the efficacy of this treatment in localized and …

Germline genetics of prostate cancer

HM Khan, HH Cheng - The Prostate, 2022 - Wiley Online Library
… , localized prostate cancer and metastatic prostate cancer carry … The data summarized in
this review has led to the expansion … nature of PALB2 in the pathogenesis of prostate cancer is …

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

A Zapatero, A Guerrero, X Maldonado… - The Lancet …, 2022 - thelancet.com
… Because of the indolent nature of prostate cancer, in 2013 and before the specified 5-year
analysis, we made an amendment to the trial (approved by the hospitals' ethics committees …

Neoadjuvant 177Lu-PSMA-I&T radionuclide treatment in patients with high-risk prostate cancer before radical prostatectomy: a single-arm phase 1 trial

S Golan, M Frumer, Y Zohar, E Rosenbaum… - European Urology …, 2023 - Elsevier
localized prostate cancer who received treatment with a radioactive agent before surgical
removal of their prostate. … The study was approved by the institutional review board and the …